Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hemo Organic Limited held its AGM on 29 September 2025 via video conferencing, where all 7 resolutions were passed with overwhelming shareholder approval (over 99.6% in favour on each). Key items included adoption of audited financial statements for FY ending 31 March 2025, re-appointment of Managing Director Vishwambar Kameshwar Singh (who retires by rotation), and regularization of Deepak Ashokkumar Rochani as Independent Director. Special business resolutions covered approval of enhanced borrowing limits under Section 180(1)(C), authority to sell or dispose of undertakings, Section 186 authorisation for loans and investments (in which promoters were interested), and approval of loans to directors under Section 185. Voting turnout was about 21% of the 34.65 lakh outstanding shares, with promoters (5.84 lakh shares, ~16.8% stake) voting unanimously in favour and only 2,653 dissenting votes from public non-institutional holders.
Routine procedural clearance — no major governance surprises or red flags. Shareholders have authorised broader borrowing powers and asset disposal flexibility, which gives the management more financial headroom but also greater discretion. Minority dissent was negligible, suggesting smooth shareholder relations.